Amyloidogenic metal-binding proteins: new investigative pathways
Paul Davies1, Sarah N Fontaine, Dima Moualla
1Department of Biology and Biochemistry, University of Bath, Bath, UK.
Biochemical Society Transactions
|November 22, 2008
Summary
Certain neurodegenerative diseases involve proteins that bind copper, influencing aggregation and function. This review explores common research approaches for studying amyloid precursor protein, prion protein, and alpha-Synuclein copper interactions.
Area of Science:
- Biochemistry
- Neuroscience
- Molecular Biology
Background:
- Neurodegenerative diseases are complex, with some linked to protein aggregation.
- Amyloidogenic proteins like APP, PrP, and alpha-Synuclein share copper-binding properties.
- Copper binding influences protein aggregation, function, and disease pathology.
Purpose of the Study:
- To review common research approaches for studying copper-binding proteins implicated in neurodegeneration.
- To highlight similarities in copper interactions across different neurodegenerative disease-associated proteins.
Main Methods:
- Comparative analysis of copper-binding mechanisms in APP, PrP, and alpha-Synuclein.
- Review of experimental techniques used to study protein-copper interactions.
- Discussion of how copper influences protein aggregation and function.
Main Results:
- Copper binding is a shared characteristic of APP, PrP, and alpha-Synuclein.
- Copper interactions modulate the aggregation propensity and function of these proteins.
- Similar research methodologies can be applied to study these diverse proteins.
Conclusions:
- Copper binding represents a unifying feature in specific neurodegenerative diseases.
- Understanding these copper interactions is crucial for developing targeted therapeutic strategies.
- Further research using shared approaches can advance our knowledge of these diseases.
More Related Videos
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...